Document is current
Any future updates will be listed below
-
Authors
Haebe, Sarah
Czerwinski, Debra K.
Sathe, Anuja
Grimes, Susan M.
Chen, Tianqi
Suarez, Carlos J.
Martin, Brock
Ji, Hanlee P.
Levy, Ronald
Shree, Tanaya https://orcid.org/0000-0003-0694-3512
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | National Institutes of Health (K08CA252637)
National Heart and Lung Institute (5T32HL120824-04)
Leukemia and Lymphoma Society (TRP 6539-18)
Deutsche Krebshilfe (Max-Eder Program 70116606)
Ludwig Maximilians University Munich | Medizinischen Fakultät, Ludwig-Maximilians-Universität München (Medical and Clinician Scientist Program (MSCP),)
- License Information
-
More Information
Article History
Received: 10 February 2025
Revised: 30 May 2025
Accepted: 10 July 2025
First Online: 4 August 2025
Competing interests
: The authors declare no competing interests.
: The patient signed informed consent regarding to participate in the study. In addition, the patient signed informed consent to molecular analyses, publication of her data, and use of her imaging studies. The study was approved by the Institutional Review Board at Stanford University and conducted in accordance with good clinical practice (GCP) as defined in International Conference on Harmonization (ICH) guidelines and the US Code of Federal Regulations.
